BIOMAT Database Logo BIOMAT Database Logo

Anti-ATLA (antibody to adult T-cell leukemia-lymphoma virus-associated antigen)-negative adult T-cell leukemia-lymphoma. 1983

M Shimoyama, and K Minato, and K Tobinai, and M Nagai, and T Setoya, and S Watanabe, and H Hoshino, and M Miwa, and H Nagoshi, and N Ichiki, and N Fukushima, and K Sugiura, and N Funaki

Five cases of adult T-cell leukemia-lymphoma (ATL) having typical clinicohematologic and morphologic features but negative for anti-ATLA [antibody to ATL virus (ATLV)-associated antigen (ATLA)] are presented. Some differences in immunologic, epidemiologic, and serologic data between anti-ATLA-positive and -negative ATLs are also described. Expression of ATLA in early primary cultured leukemic cells was found to be negative in three patients tested (Cases 1, 2 and 4), however, a long-term cultured cell line, ATL-6A, derived from peripheral blood leukemia cells from Case 1, was found to express ATLA. Mother of Case 1 and a daughter of Case 2 were anti-ATLA negative. These results indicate that ATLV was involved in certain anti-ATLA-negative ATL patients, at least in Case 1, and that the patient had no detectable immune response against ATLV and ATLA. However, in other cases in which no ATLA reactivity of serum and no ATLA expression in cultured leukemic cells were observed, another possibility such as activation of an unknown cellular oncogene specific for ATL without ATLV involvement may be considered. In order to prove these possibilities definitely, it is necessary to elucidate whether or not proviral DNA of ATLV is integrated into chromosomal DNA of ATL cells and to find a cellular oncogene specific for ATL in the future.

UI MeSH Term Description Entries
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D008223 Lymphoma A general term for various neoplastic diseases of the lymphoid tissue. Germinoblastoma,Lymphoma, Malignant,Reticulolymphosarcoma,Sarcoma, Germinoblastic,Germinoblastic Sarcoma,Germinoblastic Sarcomas,Germinoblastomas,Lymphomas,Lymphomas, Malignant,Malignant Lymphoma,Malignant Lymphomas,Reticulolymphosarcomas,Sarcomas, Germinoblastic
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

M Shimoyama, and K Minato, and K Tobinai, and M Nagai, and T Setoya, and S Watanabe, and H Hoshino, and M Miwa, and H Nagoshi, and N Ichiki, and N Fukushima, and K Sugiura, and N Funaki
[Adult T-cell leukemia/lymphoma associated with unusual positivity of anti-ATLA (adult T-cell leukemia-cell-associated antigen) antibodies].
March 1990, [Rinsho ketsueki] The Japanese journal of clinical hematology,
M Shimoyama, and K Minato, and K Tobinai, and M Nagai, and T Setoya, and S Watanabe, and H Hoshino, and M Miwa, and H Nagoshi, and N Ichiki, and N Fukushima, and K Sugiura, and N Funaki
Low prevalence of antibody to adult T-cell leukemia-associated antigen (anti-ATLA) in hospital personnel.
January 1987, The Kurume medical journal,
M Shimoyama, and K Minato, and K Tobinai, and M Nagai, and T Setoya, and S Watanabe, and H Hoshino, and M Miwa, and H Nagoshi, and N Ichiki, and N Fukushima, and K Sugiura, and N Funaki
[Detection of adult T-cell leukemia-associated antigen (ATLA) and anti-ATLA antibody (anti-ATLA) in patients with hematologic malignancies in the Kagoshima district].
August 1987, Igaku kenkyu. Acta medica,
M Shimoyama, and K Minato, and K Tobinai, and M Nagai, and T Setoya, and S Watanabe, and H Hoshino, and M Miwa, and H Nagoshi, and N Ichiki, and N Fukushima, and K Sugiura, and N Funaki
[Detection of antibody to adult T cell leukemia associated antigen (ATLA) utilizing laser flow cytometry].
October 1985, [Rinsho ketsueki] The Japanese journal of clinical hematology,
M Shimoyama, and K Minato, and K Tobinai, and M Nagai, and T Setoya, and S Watanabe, and H Hoshino, and M Miwa, and H Nagoshi, and N Ichiki, and N Fukushima, and K Sugiura, and N Funaki
[Detection of anti-ATLA (adult T cell leukemia cell associated antigen) antibody in Nagasaki District, ATL-endemic area].
March 1984, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
M Shimoyama, and K Minato, and K Tobinai, and M Nagai, and T Setoya, and S Watanabe, and H Hoshino, and M Miwa, and H Nagoshi, and N Ichiki, and N Fukushima, and K Sugiura, and N Funaki
[Clinical significance of adult T-cell leukemia (ATL)-associated antigens (ATLA), anti-ATLA antibody and adult T-cell leukemia virus (ATLV)/human T-cell leukemia virus type-I (HTLV-I) proviral DNA in ATL, adult T-cell malignant lymphoma (AT-ML) and Hodgkin's disease in Kagoshima district].
September 1986, [Rinsho ketsueki] The Japanese journal of clinical hematology,
M Shimoyama, and K Minato, and K Tobinai, and M Nagai, and T Setoya, and S Watanabe, and H Hoshino, and M Miwa, and H Nagoshi, and N Ichiki, and N Fukushima, and K Sugiura, and N Funaki
[Antibodies to adult T-cell leukemia-associated antigen (ATLA) in kidney transplant recipients].
September 1987, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
M Shimoyama, and K Minato, and K Tobinai, and M Nagai, and T Setoya, and S Watanabe, and H Hoshino, and M Miwa, and H Nagoshi, and N Ichiki, and N Fukushima, and K Sugiura, and N Funaki
[Anti-ATLA (antibodies to adult T-cell leukemia-associated antigen) in the East coast of Kii Peninsula].
October 1985, [Rinsho ketsueki] The Japanese journal of clinical hematology,
M Shimoyama, and K Minato, and K Tobinai, and M Nagai, and T Setoya, and S Watanabe, and H Hoshino, and M Miwa, and H Nagoshi, and N Ichiki, and N Fukushima, and K Sugiura, and N Funaki
Adult T-cell leukemia-associated antigen (ATLA) and anti-ATLA antibodies in patients with Hodgkin's disease in the Nagasaki District.
January 1983, Japanese journal of clinical oncology,
M Shimoyama, and K Minato, and K Tobinai, and M Nagai, and T Setoya, and S Watanabe, and H Hoshino, and M Miwa, and H Nagoshi, and N Ichiki, and N Fukushima, and K Sugiura, and N Funaki
Adult T-cell leukemia-associated antigen (ATLA): detection of a glycoprotein in cell- and virus-free supernatant.
January 1982, Zeitschrift fur Naturforschung. Section C, Biosciences,
Copied contents to your clipboard!